Stay updated on Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial page.

Latest updates to the Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial page
- Check5 days agoChange DetectedA site-wide notice was added announcing NIH website updates and explaining the transition from the term “artificial intelligence” to “super intelligence” in some NIH content.SummaryDifference1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check19 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe study record now displays a 403 Forbidden page instead of the usual study details, with a 403 header and standard site footer indicating the record is not accessible.SummaryDifference17%

- Check62 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This seems to be a minor software update that does not alter the study content.SummaryDifference0.0%

- Check76 days agoChange DetectedIPD sharing information was added to the study page, including access criteria, plan details, and related links. This addition describes how de-identified participant data may be accessed and shared for research purposes.SummaryDifference82%

Stay in the know with updates to Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Saxa/Dapa + Metformin vs Glimep + Metformin: Type 2 Diabetes Clinical Trial page.